Streetbeat News

Stock Prices

CLOV

Clover Health's shares are trading lower following the release of their Q3 financial results.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 6:12 pm

OLPX

Olaplex reported better-than-expected Q3 financial results and revised its FY23 revenue guidance above estimates, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 6:11 pm

ALTO

PXMD

SNTI

VTYX

The article lists the stocks that gained and lost the most in Tuesday's mid-day session. Among the gainers were PaxMedica, Senti Biosciences, Tharimmune, TransMedics Group, and Singular Genomics Systems. Among the losers were Ventyx Biosciences, Alto Ingredients, Worldwide Webb Acquisition Corp, Oportun Financial Corporation, and Royalty Management Holding Corporation.

Portfolio Pulse from Lisa Levin

November 07, 2023 | 6:10 pm

BNBUSD

BTCUSD

CryptoQuant's J. A. Maartunn warns of potential crypto market turbulence, citing a metric that currently stands at $13.8 billion, which could be a precursor to market turbulence. Historically, whenever this metric crossed the $12.2 billion mark, it led to at least a 20% drop in Bitcoin value. CryptoSlate's James Van Straten also noted a significant uptick in the open interest in Bitcoin, which may indicate a shift in investor sentiment or the adoption of defensive strategies amidst market uncertainty.

Portfolio Pulse from Murtuza Merchant

November 07, 2023 | 6:08 pm

GEO

The GEO Group Inc reported Q3 FY23 revenue of $602.8 million, beating the consensus of $595.3 million. Adjusted EPS of $0.19 came in line with the consensus. The company reduced total net debt by $109 million, ending the quarter with approximately $1.8 billion in total net debt. GEO lowered its Q4 revenue outlook to $590 million-$600 million and revised its FY23 Adjusted EBITDA outlook to $495 million-$500 million. The company's shares are trading higher by 4.13% at $9.32.

Portfolio Pulse from Lekha Gupta

November 07, 2023 | 6:08 pm

JEPI

SPYI

The JPMorgan Equity Premium Income ETF (JEPI) and the NEOS S&P 500 High Income ETF (SPYI) are both options-based high-income ETFs. JEPI, with over $29 billion in assets under management, provides consistent monthly income and lower volatility, but struggles to capture total return against its benchmark index during bullish times. SPYI, on the other hand, has been able to capture over 97% of the S&P 500’s total return year-to-date while paying a 12.19% annual distribution yield to its investors. The author suggests that these two ETFs can complement each other in an income-focused investor's portfolio.

Portfolio Pulse from Austin Hankwitz

November 07, 2023 | 6:05 pm

ELAN

Elanco Animal Health Inc (ELAN) reported Q3 FY23 revenue of $1.068 billion, surpassing the consensus of $1.04 billion. Adjusted EPS was $0.18, up from $0.17 a year ago, beating both management guidance and analysts' expectations. The company raised its FY23 revenue guidance to $4.36 billion-$4.4 billion. ELAN shares are up 13.30% at $10.60.

Portfolio Pulse from Vandana Singh

November 07, 2023 | 6:04 pm

OLO

Olo's shares are trading lower following the release of its Q3 financial results.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 6:04 pm

BNGO

Bionano Genomics (NASDAQ:BNGO) is set to release its latest quarterly earnings report on November 8, 2023. Analysts estimate an earnings per share (EPS) of $-0.94. The company's past performance shows a trend of missing EPS estimates, which has led to share price drops. The stock is currently trading at $1.63, down 92.9% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 6:02 pm

MTNB

Matinas BioPharma Hldgs (AMEX:MTNB) is set to release its latest quarterly earnings report on November 8, 2023. Analysts estimate an earnings per share (EPS) of $-0.03. The company's past performance shows a trend of missing EPS estimates, which has led to significant drops in share price. The company's shares are currently trading at $0.2516 and have seen a 60.21% decrease over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 6:02 pm